Interested to learn more about Pharma VC? See our previous write up (L!nk in b!o) https://t.co/v0YSopTJWK https://t.co/syRTa7JSwN
🚨 INNOVATORS TAKE NOTE: a new $500M VC fund from $REGN to fuel biotech innovation! https://t.co/8CfhftCiFt https://t.co/yvzJi4YZkn
Regeneron commits $500M to new venture capital fund https://t.co/gaOsLXb4Ka $REGN by @Lilah_Alvarado
Regeneron Pharmaceuticals has launched its first corporate venture capital fund, committing $500 million to invest in biotechnology, healthcare, and health technology startups over the next five years. The fund, known as Regeneron Ventures, will allocate $100 million annually and is based in Greenwich, CT. It will be led by former Regeneron executives Michael Aberman and Jay Markowitz, focusing on long-term investments across various therapeutic areas, technologies, and development stages. Additionally, Regeneron's stock has seen a significant increase, rising 4,996% since its IPO.
